CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Wounds and Injuries D014947 20 associated lipids
Wiskott-Aldrich Syndrome D014923 3 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Uremia D014511 33 associated lipids
Tuberculosis D014376 20 associated lipids
Trisomy D014314 6 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Michelakakis H and Danpure CJ The effect of cytochalasin B on the release of lysosomal enzymes and intra-lysosomally-stored polyvinylpyrrolidone in the isolated perfused rat liver. 1984 Biochem. Pharmacol. pmid:6430298
Elferink JG Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. 1979 Biochem. Pharmacol. pmid:375938
Tsuruo T and Iida H Effects of cytochalasins and colchicine on the accumulation and retention of daunomycin and vincristine in drug resistant tumor cells. 1986 Biochem. Pharmacol. pmid:3457567
Skidgel RA et al. Metabolism of substance P and bradykinin by human neutrophils. 1991 Biochem. Pharmacol. pmid:1708255
Smith RJ and Iden SS Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophils. Effects of prostaglandins, nonsteroid anti-inflammatory agents and corticosteroids. 1980 Biochem. Pharmacol. pmid:7426044
Theodoropoulos PA et al. Cytochalasin B may shorten actin filaments by a mechanism independent of barbed end capping. 1994 Biochem. Pharmacol. pmid:8204105
Smith RJ et al. Stimulation of the human neutrophil superoxide anion-generating system with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine. 1984 Biochem. Pharmacol. pmid:6324816
Zhou HL et al. Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophils. 1993 Biochem. Pharmacol. pmid:8394074
Fujita H et al. Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. 2005 Biochem. Pharmacol. pmid:15869745
Michelakakis H and Danpure CJ The release of intralysosomally-stored 125I-Triton WR-1339 and lysosomal enzymes from the isolated perfused rat liver in the presence and absence of cytochalasin B. 1986 Biochem. Pharmacol. pmid:3082335
Soares-da-Silva P Actin cytoskeleton, tubular sodium and the renal synthesis of dopamine. 1992 Biochem. Pharmacol. pmid:1449540
DoKhac L et al. Differential role of microtubules in the control of prostaglandin E2 and beta-adrenergic stimulation of cyclic AMP accumulation in the rat myometrium. 1983 Biochem. Pharmacol. pmid:6193795
Trush MA et al. Oxidant-mediated electronic excitation of imipramine. 1984 Biochem. Pharmacol. pmid:6329228
Lucas M and Solano F Opposite effect of cytochalasin B on agonist-induced respiratory burst in neutrophils and monocytes. 1991 Biochem. Pharmacol. pmid:1859454
Kim JY et al. Src-mediated regulation of inflammatory responses by actin polymerization. 2010 Biochem. Pharmacol. pmid:19769947
Malaisse WJ et al. The coupling of metabolic to secretory events in pancreatic islets: inhibition by 2-cyclohexene-1-one of the secretory response to cyclic AMP and cytochalasin B. 1986 Biochem. Pharmacol. pmid:2877668
Smith RJ et al. Human neutrophil activation with interleukin-1. A role for intracellular calcium and arachidonic acid lipoxygenation. 1987 Biochem. Pharmacol. pmid:2825706
Smith RJ Phagocytic release of lysosomal enzymes from guinea pig neutrophils--regulation by corticosteroids, autonomic neurohormones and cyclic nucleotides. 1977 Biochem. Pharmacol. pmid:21664
Stournaras C et al. Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. 1996 Biochem. Pharmacol. pmid:8937443
Morita K et al. Effects of cytoskeleton-disrupting drugs on ouabain-stimulated catecholamine secretion from cultured adrenal chromaffin cells. 1988 Biochem. Pharmacol. pmid:3401261
Michelakakis H and Danpure CJ The effect of cytochalasin B on the release of lysosomal enzymes from isolated rat hepatocytes [proceedings]. 1979 Biochem. Soc. Trans. pmid:119657
Walmsley AR et al. The pre-steady-state kinetics of conformational changes in sugar transporters. 1994 Biochem. Soc. Trans. pmid:7821656
al-Habori M et al. Cytochalasins potently inhibit glycogen synthesis in hepatocyte cultures by an indirect mechanism. 1991 Biochem. Soc. Trans. pmid:1794472
Michelakakis H and Danpure CJ The uptake and release of lysosomal enzymes by isolated perfused rat liver. 1980 Biochem. Soc. Trans. pmid:6778741
Drewes LR et al. Inhibition of unidirectional influx of glucose into the isolated perfused dog brain by cytochalasin B. 1976 Biochem. Soc. Trans. pmid:1001606
Schmitt M and Bültmann B Fluorescent chemotactic peptides as tools to identify the f-Met-Leu-Phe receptor on human granulocytes. 1990 Biochem. Soc. Trans. pmid:2379691
Brant AM et al. Immunological identification of five members of the human facilitative glucose transporter family. 1992 Biochem. Soc. Trans. pmid:1426534
O'Dowd Y and Newsholme P Regulation of superoxide production in human polymorphonuclear leukocytes (PMNs). 1997 Biochem. Soc. Trans. pmid:9191411
Charalambous BM et al. Detection of proton-linked sugar transport proteins in Enterobacteriaceae. 1989 Biochem. Soc. Trans. pmid:2546838
Hales CN et al. Sugar transport in lysosomes? 1982 Biochem. Soc. Trans. pmid:7199491
Jones MN and Nickson JK The human erythrocyte monosaccharide transporter in bilayer lipid membranes. 1982 Biochem. Soc. Trans. pmid:7199492
Haslam RJ and Lynham JA Increased phosphorylation of specific blood platelet proteins in association with the release reaction. 1976 Biochem. Soc. Trans. pmid:187490
Dean RT Effects of cytochalasin B on the pinocytosis and degradation of proteins by macrophages [proceedings]. 1979 Biochem. Soc. Trans. pmid:570939
Coderre PE et al. Rapid substrate translocation by the multisubunit, erythroid glucose transporter requires subunit associations but not cooperative ligand binding. 1995 Biochemistry pmid:7626647
Connolly TJ et al. Effects of bilayer cholesterol on human erythrocyte hexose transport protein activity in synthetic lecithin bilayers. 1985 Biochemistry pmid:4040391
Mrotek JJ and Hall PF Response of adrenal tumor cells to adrenocorticotropin: site of inhibition by cytochalasin B. 1977 Biochemistry pmid:196628
Hayden SM et al. Analysis of the interactions of actin depolymerizing factor with G- and F-actin. 1993 Biochemistry pmid:8399168
Hah JS et al. Effects of physical states of phospholipids on the incorporation and cytochalasin B binding activity of human erythrocyte membrane proteins in reconstituted vesicles. 1983 Biochemistry pmid:6626531
Tai PK and Carter-Su C Monoclonal antibody to the human glucose transporter that differentiates between the glucose and nucleoside transporters. 1988 Biochemistry pmid:3191107
Bloch R Inhibition of glucose transport in the human erythrocyte by cytochalasin B. 1973 Biochemistry pmid:4773858
Carruthers A and Helgerson AL Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. 1991 Biochemistry pmid:2018762
Himmelreich U et al. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. 1998 Biochemistry pmid:9585573
Robichaud T et al. Determinants of ligand binding affinity and cooperativity at the GLUT1 endofacial site. 2011 Biochemistry pmid:21384913
Brekkan E et al. Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter. 1996 Biochemistry pmid:8810921
May JM et al. Localization of a reactive exofacial sulfhydryl on the glucose carrier of human erythrocytes. 1990 Biochemistry pmid:2261480
Sampath P and Pollard TD Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. 1991 Biochemistry pmid:1899622
Sogin DC and Hinkle PC Binding of cytochalasin B to human erythrocyte glucose transporter. 1980 Biochemistry pmid:7192569
Carruthers A Anomalous asymmetric kinetics of human red cell hexose transfer: role of cytosolic adenosine 5'-triphosphate. 1986 Biochemistry pmid:3718945
Katzen HM et al. Evidence that the insulin-like activities of concanavalin A and insulin are mediated by a common insulin receptor linked effector system. 1981 Biochemistry pmid:7028110
Anichini E et al. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. 1997 Biochemistry pmid:9115983